Active

ABBVIE

Switched

BE0845096860

Rechtspersoon Public limited company 2 establishments

Avenue Einstein 14, 1300 Wavre Groothandel in farmaceutische en medische artikelen

Active for

14 year, 5 months

Financials

Financial year 2025

Revenue

€ 265.6 million

▲ 14% vs 2024

Profit

Healthy

€ 6.4 million

▼ 3% vs 2024

Debts

Low

€ 41.4 million

▼ 5% vs 2024

ABBVIE from Wavre, company number BE0845096860, closed financial year 2025 with a result of € 6.4 million after tax. For that financial year ABBVIE recorded revenue of € 265.6 million and equity of € 182.7 million. Compared with financial year 2024, the result moved from € 6.6 million to € 6.4 million. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 8, 2026.

What happened at ABBVIE?

What happened at ABBVIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Erica Silbiger stepped down as director. NBB
  • Renaud Decroix stepped down as director. NBB
  • New annual accounts for financial year 2025: profit of € 6.4 million (▼ 3% vs 2024). Source: NBB ↗
  • Arnaud Jean Jacques Coint-Bavarot stepped down as director. NBB
  • Erica Silbiger became a director. NBB
  • Rolfe van de Spreng stepped down as director. NBB
  • Rolfe van de Spreng became a director. NBB
  • Jean Antoine De Los Frailes stepped down as director. NBB

In short

From € 6.3 million profit in 2023 to € 6.4 million profit in 2025.

Paid € 11.5 million in corporate taxes since 2023.

Best year ever: 2024, with € 6.6 million profit.

Paid out € 25.3 million in dividends to the owners in total.

A new publication or filing at ABBVIE? We notify you, reason included.

Follow ABBVIE

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

AbbVie Central Finance B.V. 100%
ABBVIE
AbbVie SRL 100%
AbbVie Lda 99.8%

The shares are held by AbbVie Central Finance B.V. (100%). It owns 100% of AbbVie SRL and 99.8% of AbbVie Lda itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Erica Silbiger

Director

Also active at: SYNDESI THERAPEUTICS

since 2026 · until 2028

Arnaud Jean Jacques Coint-Bavarot

Director

since 2022 · until 2026

Rolfe van de Spreng

Director

Also active at: SYNDESI THERAPEUTICS

since 2025 · until 2026

Jean Antoine De Los Frailes

Director

since 2017 · until 2025

Renaud Decroix

Chairman of the board

since 2024 · until 2027

Shareholders

AbbVie Central Finance B.V.

100%

Participations

AbbVie SRL

100%

AbbVie Lda

99.8%

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue Einstein 14

1300 Wavre

2.239.363.675

de Meeûssquare 37

1000 Brussel

Active since 1 March 2015

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

Details

Company number
0845.096.860
VAT number
BE 0845.096.860
Registered office
Avenue Einstein 14, 1300 Wavre
Names & denominations
ABBVIE
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
5 April 2012
Peppol
Active · Active since 27 Aug 2020
Activities · NACE

Groothandel in farmaceutische en medische artikelen

Frequently asked questions

What is the enterprise number of ABBVIE?
The enterprise number of ABBVIE is BE0845096860.
What is the address of ABBVIE?
The registered office of ABBVIE is located at Avenue Einstein 14, 1300 Wavre.
When was ABBVIE founded?
ABBVIE was founded on 5 April 2012.
What is the main activity of ABBVIE?
The main activity of ABBVIE is "Groothandel in farmaceutische en medische artikelen" (NACE code 46460).
Does ABBVIE have a website?
No website is currently known for ABBVIE.
How much profit did ABBVIE make in 2025?
ABBVIE posted a profit after taxes of € 6,448,196 in financial year 2025.
What is the revenue of ABBVIE?
In its most recent annual accounts (2025), ABBVIE reported revenue of € 265,550,630.
How many employees does ABBVIE have?
According to the 2025 annual accounts, ABBVIE has 213.4 full-time equivalents (FTE).
Where can I find the annual accounts of ABBVIE?
ABBVIE files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of ABBVIE?
According to the 2025 annual accounts, the directors of ABBVIE are: Erica Silbiger, Arnaud Jean Jacques Coint-Bavarot, Rolfe van de Spreng, Jean Antoine De Los Frailes, Renaud Decroix.
Who owns ABBVIE?
The shares are held by AbbVie Central Finance B.V. (100%). It owns 100% of AbbVie SRL and 99.8% of AbbVie Lda itself.
Who are the shareholders of ABBVIE?
According to the 2025 annual accounts, the shareholders of ABBVIE are: AbbVie Central Finance B.V. (100%).